SCHEMBL9014641

SCHEMBL9014641

CCOCOc1c(C(C)(C)C)c[c]cc1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4796005 0.81
SCHEMBL6111734 0.81
SCHEMBL9014507 0.74 HMGCR (0.33)
SCHEMBL8768660 0.70 CYP3A4 (0.39)
SCHEMBL24823151 0.70 ALDH1A1 (0.51)
SCHEMBL458512 0.69 PTGS2 (0.39)
SCHEMBL8768656 0.68 VCAM1 (0.36)
SCHEMBL3688047 0.68
SCHEMBL28381171 0.67 PTGS2 (0.38)
SCHEMBL23906793 0.67 PIM1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0585155-B1 Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition ADIR (FR) 1996-12-11 EP claimed
US-5565429-A HUMAN LEUCOCYTE ELASTASE INHIBITORS; EMPHYSEMA; ANTIARTHRITIC AGENTS; RHEUMATIC DISEASES ADIR ET COMPAGNIE (FR) 1996-10-15 US claimed
EP-0585155-A1 Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition ADIR ET COMPAGNIE (FR) 1994-03-02 EP claimed
EP-0585155-B1 Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition ADIR (FR) 1996-12-11 EP disclosed
US-5565429-A HUMAN LEUCOCYTE ELASTASE INHIBITORS; EMPHYSEMA; ANTIARTHRITIC AGENTS; RHEUMATIC DISEASES ADIR ET COMPAGNIE (FR) 1996-10-15 US disclosed
EP-0585155-A1 Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition ADIR ET COMPAGNIE (FR) 1994-03-02 EP disclosed